Cancer & Advanced Surgical Treatments

Robotic prostatectomy is a minimally invasive robotic operation to remove the prostate, primarily to treat prostate cancer. Surgeons operate through a state-of-the-art robotic platform that delivers magnified 3D visualization and exceptional instrument precision inside the pelvis.

Compared with traditional open surgery, the small-incision approach means less blood loss, less postoperative pain, shorter hospital stays, and faster overall recovery for appropriately selected patients.

When oncologically appropriate, the procedure uses careful nerve-sparing technique to help preserve urinary continence and sexual function after surgery, in addition to removing the cancer.

It is a cornerstone oncologic procedure in the practice and is performed by fellowship-trained specialists with extensive robotic experience.

Robotic partial nephrectomy is a kidney-preserving robotic operation that removes a tumor while sparing the surrounding healthy kidney. It is used to treat many localized kidney cancers.

The robotic platform provides precise dissection and intracorporeal reconstruction in a confined anatomic space, allowing tumor removal followed by careful suturing of the remaining kidney.

Preserving functional kidney tissue lowers the long-term risk of chronic kidney disease compared with removing the entire kidney, which is particularly important for patients with cardiovascular disease, diabetes, or only one healthy kidney.

Recovery is generally faster than with open surgery due to the minimally invasive approach, with most patients returning to normal activity within weeks.

MRI fusion prostate biopsy is an advanced biopsy technique that merges previously captured multiparametric MRI images with live ultrasound to precisely target suspicious areas in the prostate.

Compared with traditional random sampling, fusion-guided biopsy improves detection of clinically significant cancers and reduces over-sampling of insignificant disease.

The procedure is typically performed in-office under local anesthesia. Fusion software allows the urologist to direct the needle to specific MRI-defined lesions in real time.

The result is a more accurate diagnosis and better-informed decisions about active surveillance, surgery, focal therapy, or radiation.

Focal therapy is a targeted treatment approach that destroys only the cancerous portion of the prostate while sparing surrounding healthy tissue. It is an option for carefully selected patients with localized, well-characterized disease.

By treating a focal region rather than the entire gland, the approach aims to reduce the side-effect burden seen with whole-gland treatments, particularly incontinence and erectile dysfunction.

Techniques used in focal therapy may include high-intensity focused ultrasound (HIFU), cryotherapy, or focal laser ablation, chosen based on lesion location and patient anatomy.

Candidates are selected through detailed MRI imaging and mapping biopsy so that treatment is delivered with confidence and precision.

Laser treatments encompass a range of procedures used across urology to treat kidney and ureteral stones, obstructive prostate tissue, and certain tumors. Laser energy allows precise tissue removal or fragmentation with minimal collateral injury.

The specific laser wavelength and technique are matched to the condition. Holmium and thulium lasers, for example, are used for stones and prostate tissue, while other lasers are used for selected surface tumors.

Most laser procedures are minimally invasive and performed endoscopically through natural openings, without external incisions.

Benefits include reduced bleeding risk, often shorter recovery, and the ability to treat selected patients on blood thinners who are not candidates for other approaches.

Radiation-related urologic care is the coordinated management of patients whose treatment involves or follows radiation therapy. The practice helps plan, support, and manage urinary and sexual side effects associated with radiation.

Services include monitoring for cancer recurrence after radiation, managing late urinary side effects such as bleeding or strictures, and supporting sexual function recovery.

Care is coordinated closely with radiation oncology, medical oncology, and other specialists to ensure smooth communication and consistent decision-making.

The goal is comprehensive, continuous support throughout the entire radiation treatment journey and well into survivorship.

HIFU is a non-invasive focal therapy that uses precisely focused ultrasound energy to heat and destroy targeted prostate tissue. It is used to treat localized prostate cancer without incisions or ionizing radiation.

Because the energy is focused on a specific region, HIFU aims to limit damage to surrounding structures, helping preserve urinary and sexual function in appropriately selected patients.

The procedure is typically performed under anesthesia in a single session, with patients usually returning home the same day.

HIFU is offered to carefully selected candidates as part of an individualized plan, often after detailed MRI imaging and targeted biopsy mapping.

Cryotherapy, or cryoablation, is a focal treatment that uses extreme cold to freeze and destroy cancerous tissue, most often in the prostate or kidney.

Precision probes are placed under imaging guidance to deliver controlled freezing energy directly to the tumor while sparing surrounding healthy structures.

Targeting only the diseased tissue helps reduce side effects and shorten recovery compared with major open surgery, and can be a good option for patients who are not ideal surgical candidates.

It is minimally invasive, typically performed as an outpatient procedure, and offered as part of a carefully individualized treatment plan.

Focal laser ablation is a minimally invasive technique that uses laser energy to precisely heat and destroy a targeted area of cancerous prostate tissue.

Treatment is guided by advanced imaging so that energy is focused on the lesion identified on MRI and biopsy, sparing the remainder of the gland.

By preserving the rest of the prostate, the approach helps maintain urinary and sexual function while controlling the targeted disease.

It is an option for select patients with localized, well-characterized prostate cancer and is typically completed with minimal downtime.